RVMD insider trading
HealthcareRevolution Medicines, Inc.: insider trade history from SEC Form 4 filings.
About Revolution Medicines, Inc.
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Company website: www.revmed.com
RVMD insider activity at a glance
FilingIQ tracks 783 insider transactions for RVMD in filings since Feb 18, 2020. The most recent transaction is dated Sep 29, 2026.
Across the full history, 40 open-market purchases
and 466 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on RVMD insider trades is 58.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest RVMD Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding RVMD
Frequently asked
- How many insider trades does FilingIQ track for RVMD?
- FilingIQ tracks 783 Form 4 insider transactions for RVMD (Revolution Medicines, Inc.), covering filings from Feb 18, 2020 onwards. 88 of those are dated within the last 90 days.
- Are RVMD insiders net buyers or net sellers?
- Across the full Form 4 history for RVMD, 40 transactions (5%) were open-market purchases and 466 (60%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does RVMD insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is RVMD in?
- Revolution Medicines, Inc. (RVMD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $18.93B.
Methodology & sources
Every RVMD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.